Skip to main content
. 2018 Oct;10(10):5904–5912. doi: 10.21037/jtd.2018.09.108

Figure 3.

Figure 3

Correlation between EGFR alterations and clinical features. (A) EGFR mutation was correlated with early-stage. (B) EGFR alterations were more prone to occur in adenocarcinoma than squamous cell carcinoma. (C,D) Tumors with EGFR mutation were more likely to have alveolar (C) and papillary (D) components. (E,F,G) Tumors with EGFR mutations commonly have overexpressed TTF-1 (E) and lower expressed P40 (F) and Ki67 (G).